Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.7 USD | +6.63% | +9.14% | +117.65% |
Apr. 25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 24.5M |
---|---|---|---|---|---|
Net income 2022 | -9M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 42.06M | Net cash position 2023 | 37.15M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.44
x | P/E ratio 2023 |
-4.59
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.71% |
1 day | +6.63% | ||
1 week | +9.14% | ||
1 month | +13.85% | ||
3 months | +121.56% | ||
6 months | +102.19% | ||
Current year | +117.65% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 06-09-30 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 21-05-09 |
Sharon Perry
LAW | General Counsel | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 17-02-15 |
Robert Conway
CHM | Chairman | 70 | 13-09-02 |
Linda Grais
BRD | Director/Board Member | 68 | 07-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.7 | +6.63% | 81,280 |
24-05-30 | 3.47 | +1.17% | 16,045 |
24-05-29 | 3.43 | -3.38% | 21,830 |
24-05-28 | 3.55 | +4.72% | 51,074 |
24-05-24 | 3.39 | +3.99% | 46,889 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+117.65% | 53.68M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.67% | 12.27B |
- Stock Market
- Equities
- ABIO Stock